Cromolyn Sodium API Market
Cromolyn Sodium API Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cromolyn Sodium API Market Size and Growth
The Cromolyn Sodium API market exhibits steady growth, driven by increasing respiratory disorders and demand for allergy treatments. The global market size is estimated to reach approximately $750 million by 2025, reflecting analytical trends in healthcare investments and evolving pharmaceutical developments. Competitive dynamics emphasize innovation and regulatory advancements in production. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Cambrex
◍ SIMS Srl
◍ DEAFARMA
◍ LGM Pharma
◍ P&R SpA
◍ JSN Chemicals
◍ Xian Hench Biotechnology
◍ Fermion Oy
◍ Sanofi Active Ingredient Solutions
◍ Egis Pharmaceuticals PLC
The Cromolyn Sodium API market is supported by companies like Cambrex, SIMS Srl, and Sanofi Active Ingredients. These firms manufacture and supply highquality Cromolyn Sodium for pharmaceuticals, aiding market growth through innovative production, strategic partnerships, and expanding application in allergy treatments. Sales revenues for some companies include:
- Cambrex: $800 million
- Sanofi: €37 billion
- LGM Pharma: $200 million
Request Sample Report
Market Segmentation
By Application
Eye Drops
Inhalent
Tablets
Others
Request Sample Report
By Product
Abrove Purity 98%
Purity 99%
Market Growth
Request Sample Report
$ X Billion USD
